Jessica Grigoletto
Jerusalem, JM 91120, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Velusetrag rescues GI dysfunction, gut inflammation and dysbiosis in a mouse model of Parkinson's disease.
Journal: NPJ Parkinson's disease
Published: February 24, 2023
Alpha-Synuclein and Parkinson's Disease Motor and Non-Motor Symptoms: What Is New?
Journal: Life (Basel, Switzerland)
Published: June 10, 2022
Ischemic stroke causes Parkinson's disease-like pathology and symptoms in transgenic mice overexpressing alpha-synuclein.
Journal: Acta neuropathologica communications
Published: December 14, 2021
Loss of Corticostriatal Mu-Opioid Receptors in α-Synuclein Transgenic Mouse Brains.
Journal: Life (Basel, Switzerland)
Published: November 29, 2021
A role for α-Synuclein in axon growth and its implications in corticostriatal glutamatergic plasticity in Parkinson's disease.
Journal: Molecular neurodegeneration
Published: December 16, 2019
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate.
Journal: Neurobiology of disease
Published: November 07, 2019
α-Synuclein in blood cells differentiates Parkinson's disease from healthy controls.
Journal: Annals of clinical and translational neurology
Published: June 04, 2019
Oral and intravenous transmission of α-synuclein fibrils to mice.
Journal: Acta neuropathologica
Published: March 29, 2019
Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons.
Journal: The Journal of pharmacology and experimental therapeutics
Published: September 14, 2017
Higher levels of myelin phospholipids in brains of neuronal α-Synuclein transgenic mice precede myelin loss.
Journal: Acta neuropathologica communications
Published: April 06, 2017
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons.
Journal: Journal of cell science
Published: June 09, 2014
Lysine residues at the first and second KTKEGV repeats mediate α-Synuclein binding to membrane phospholipids.
Journal: Neurobiology of disease
Published: January 29, 2014
Last Updated: 09/26/2026